Valo Therapeutics Appoints Michael Stein as Chief Executive Officer

Seasoned Healthcare Entrepreneur strengthens Management Team OXFORD, England and HELSINKI, June 17, 2019 -- (Healthcare Sales & Marketing Network) -- Valo Therapeutics Limited (Valo Tx), a cancer immunotherapy company developing neoantigen-coated oncol... Biopharmaceuticals, Personnel Valo Therapeutics, PeptiCRAd
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news